The Efficacy of Magnesium Supplementation in Children With Attention Deficit Hyperactivity Disorder under Treatment With Methylphenidate: A Randomized Controlled Trial

Seyed Gholamreza Noorazar; Parinaz Kalejahi; Sepideh Setayesh; Shahrokh Amiri; Neda Yasamineh

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jan 2021, Vol 8, Issue 1

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
The Efficacy of Magnesium Supplementation in Children With Attention Deficit Hyperactivity Disorder under Treatment With Methylphenidate: A Randomized Controlled Trial
Seyed Gholamreza Noorazar¹, Parinaz Kalejahi², Sepideh Setayesh¹, Shahrokh Amiri¹, Neda Yasamineh³
¹Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran ²Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ³Dental and Periodontal Research Center, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
CJMB 2021; 8: 073-076 Viewed : 1670 times Downloaded : 1733 times. Keywords : Attention deficit hyperactivity disorder, Magnesium, Methylphenidate
Full Text(PDF) \| Related Articles
Abstract

Objectives: The prevalence of attention deficit hyperactivity disorder (ADHD) in children has been rising more rapidly in recent years. Studies have shown that attention to the nutritional deficiencies in these children can be effective in controlling symptoms. Therefore, we decided to examine the magnesium supplementation in children with ADHD under treatment with methylphenidate. Materials and Methods: The study was conducted on 40 children with ADHD. The children were randomly assigned to 2 groups. The intervention group (n = 20) received magnesium tablets (10 mg/d) with methylphenidate (0.5 to 1 mg/kg/d) for eight weeks and the control group (n = 20) received placebo with methylphenidate (0.5 to 1 mg/d). Both groups were assessed before and after the intervention using the Conner"s parent rating scale. Results: At baseline, the mean total score was 74.4 ± 10.4 in the intervention group and 76.8 ± 6.6 in the control group (P = 0.79). At the end of the study, the total score of Conner"s Parent Rating Scale was 61.9 ± 11.1 in the intervention group and 68.8 ± 7.3 in the control group (P = 0.02). There was also a significant difference between the groups in the scores of the inattention subscale at the end of the study (P = 0.001). Conclusions: The findings of the present study suggest that magnesium supplementation with methylphenidate can be effective in reducing ADHD symptoms.